glutamic acid and Androgen-Independent Prostatic Cancer

glutamic acid has been researched along with Androgen-Independent Prostatic Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Holmberg, AR; Lennartsson, L; Marquez, M; Meurling, L; Nilsson, S1
Belli, ML; Celli, M; Cittanti, C; Di Iorio, V; Ferrari, M; Mezzenga, E; Monti, M; Nicolini, S; Oboldi, D; Paganelli, G; Sarnelli, A; Severi, S; Tardelli, E; Uccelli, L1

Trials

1 trial(s) available for glutamic acid and Androgen-Independent Prostatic Cancer

ArticleYear
Dosimetry of
    Molecules (Basel, Switzerland), 2019, Feb-11, Volume: 24, Issue:3

    Topics: Administration, Oral; Aged; Aged, 80 and over; Bone Marrow; Dipeptides; Glutamic Acid; Half-Life; Heterocyclic Compounds, 1-Ring; Humans; Infusions, Intravenous; Kidney; Lutetium; Male; Mannitol; Middle Aged; Parotid Gland; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radiation Dosage; Radioisotopes; Radiopharmaceuticals; Tablets

2019

Other Studies

1 other study(ies) available for glutamic acid and Androgen-Independent Prostatic Cancer

ArticleYear
Synthesis and Binding of a Novel PSMA-specific Conjugate.
    Anticancer research, 2018, Volume: 38, Issue:3

    Topics: Antigens, Surface; Cell Line, Tumor; Dextrans; Fluorescein-5-isothiocyanate; Glutamate Carboxypeptidase II; Glutamic Acid; Humans; Lysine; Male; Microscopy, Fluorescence; Molecular Targeted Therapy; Prostatic Neoplasms, Castration-Resistant; Protein Binding; Radiopharmaceuticals; Urea

2018